| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 03/11/2009 | CN101381414A Ovarian cancer anti-idiotype antibody and preparation of heat shock protein fusion protein and application |
| 03/11/2009 | CN100467604C Chimeric GFP-aequorin as bioluminescent ca<++> reporters at the single cell level |
| 03/11/2009 | CN100467600C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/11/2009 | CN100467488C Il-7 fusion proteins |
| 03/11/2009 | CN100467483C Peptide derived from a VCA-p18 capside antigen of the epstein-barr virus and the use thereof |
| 03/10/2009 | US7501497 Comprising transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptor moiety and an immunoglobulin moiety comprising a heavy chain constant region of an immunoglobulin; interfere with binding of a tumor necrosis factor receptor with its ligand; antitumor agents |
| 03/10/2009 | US7501484 Methods and DNA constructs for high yield production of polypeptides |
| 03/10/2009 | US7501265 Method for producing and cleaving a fusion proteins with an n-terminal chymosin pro-peptide |
| 03/10/2009 | US7501234 Stress proteins and uses therefor |
| 03/10/2009 | CA2145278C Target binding polypeptide |
| 03/05/2009 | WO2009028625A1 Method of binding protein to support using tamavidin |
| 03/05/2009 | WO2009026723A1 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 03/05/2009 | WO2009026692A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/05/2009 | WO2009010474A9 Antibody or fragment thereof recognizing avitagtm and uses thereof |
| 03/05/2009 | WO2009006732A9 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 03/05/2009 | US20090060909 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | CA2698076A1 Metabolic regulators |
| 03/05/2009 | CA2697529A1 Receptor-targeting reagents |
| 03/04/2009 | EP1706486B1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications |
| 03/04/2009 | EP1499736B1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 03/04/2009 | EP1432738B1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 03/04/2009 | EP1255845B1 Modified cytokines for use in cancer therapy |
| 03/04/2009 | EP1246917B1 Human stra6 polypeptides |
| 03/04/2009 | EP1181366B1 Mammalian receptor proteins; related reagents and methods |
| 03/04/2009 | EP1045861B1 Bispecific targeting moiety comprising an antibody to carcinoembryonic antigen (cea) and the ligand-binding region of the il13 receptor alpha subunit |
| 03/04/2009 | CN101379189A Modified coagulation factor VIIa with extended half-life |
| 03/04/2009 | CN101379084A Novel anticoagulant polypeptides and complex |
| 03/04/2009 | CN101379083A Apoptosis-induced protein compound and therapy application thereof |
| 03/04/2009 | CN101376887A Preparation and use of swine foot-and-mouth disease recombinant immune composite peptide |
| 03/03/2009 | US7498407 Vascular endothelial cell growth inhibitor, VEGI-192a |
| 03/03/2009 | US7498403 Peptides capable of binding to titanium silver silicone |
| 03/03/2009 | US7498165 Rapidly cleavable SUMO fusion protein expression system for difficult to express proteins |
| 03/03/2009 | US7498153 Chimeric immunogens |
| 03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
| 02/26/2009 | WO2009025300A1 Peptide capable of binding to immunoglobulin |
| 02/26/2009 | WO2009024591A1 Pvii phage display |
| 02/26/2009 | WO2009023995A1 Crystal structure of cd147 extracellular region and use thereof |
| 02/26/2009 | WO2009023955A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 02/26/2009 | WO2008151440A4 Modifying glycoprotein production in plants |
| 02/26/2009 | WO2008147143A3 Immunoglobulin fusion proteins |
| 02/26/2009 | US20090054336 Binding Agent |
| 02/26/2009 | US20090054332 Thombopoietin peptide conjugates |
| 02/26/2009 | US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
| 02/26/2009 | US20090053763 Tumor endothelial marker 7-alpha molecules and uses thereof |
| 02/26/2009 | US20090053730 Chimeric human t1r1 taste receptor polypeptides and compositions containing same |
| 02/26/2009 | US20090053252 Bimer or an oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 02/26/2009 | US20090053246 Immunoglobulin fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same |
| 02/26/2009 | US20090053173 Stabilization of such as human interleukin 11; reduced toxicity; cost effective; shelf life; SARS virus, HIV, HCV, HBV, or HAV, and the cancer diseases, such as leukemia and malignant melanoma; between a human serum albumin and an Interferon |
| 02/26/2009 | CA2697282A1 Pvii phage display |
| 02/26/2009 | CA2696027A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 02/25/2009 | EP2028266A1 Method of producing lymphocytes |
| 02/25/2009 | EP2028193A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 02/25/2009 | EP2028190A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2027874A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 02/25/2009 | EP2027264A2 Multi-gene expression vehicle |
| 02/25/2009 | EP2027260A1 Epigenetic regulatory complex for control of gene expression |
| 02/25/2009 | EP2027153A2 Dimeric molecular complexes |
| 02/25/2009 | CN101372513A SG fusion protein |
| 02/25/2009 | CN101372508A Polypeptide and use thereof |
| 02/25/2009 | CN100463962C Phenotypic screen of chimeric proteins |
| 02/25/2009 | CN100463922C Immunoassays for anti-HCV antibodies |
| 02/25/2009 | CN100463694C Virus coat protein/receptor chimeras and methods of use |
| 02/24/2009 | US7495090 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein |
| 02/24/2009 | US7494977 Polypeptides homologous to VEGF and BMP1 |
| 02/24/2009 | US7494976 Antiinflammatory agents; anticancer agents; cholesterol binding protein |
| 02/24/2009 | US7494788 Entropic bristle domain sequences and their use in recombinant protein production |
| 02/24/2009 | US7494785 Recombinant subunit vaccine |
| 02/24/2009 | CA2414978C Preparation of a recombinant protein in a prokaryotic host cell |
| 02/24/2009 | CA2245497C Peptide immunogens for vaccination against and treatment of allergy |
| 02/19/2009 | WO2008101671A9 Il-4 fc fusion proteins |
| 02/19/2009 | US20090047736 Human T1R2 nucleic acid sequences and polypeptides |
| 02/19/2009 | US20090047668 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 02/19/2009 | CA2695374A1 Compositions and methods for modifying properties of biologically active polypeptides |
| 02/18/2009 | EP2025757A2 Polymeric immunoglobulin receptor-mediated gene transfer |
| 02/18/2009 | EP2025754A2 Moraxella (Branhamella) catarrhalis antigens |
| 02/18/2009 | EP2025345A1 KIM-1 antagonists and use to modulate immune system |
| 02/18/2009 | EP2024396A2 Plad domain peptides with increased serum half life due to conjugation to domain antibodies |
| 02/18/2009 | EP1569958B1 Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment |
| 02/18/2009 | CN101367869A Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same |
| 02/17/2009 | US7491809 Polynucleotides encoding human cytokine receptor |
| 02/17/2009 | US7491801 Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 02/17/2009 | CA2318030C Acpl dna and polypeptides |
| 02/17/2009 | CA2164984C Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/17/2009 | CA2138928C Immunoconjugates |
| 02/17/2009 | CA2121498C Recombitope peptides |
| 02/17/2009 | CA1341591C Detoxification of pertussis toxin |
| 02/12/2009 | WO2009020197A1 Fluorescent protein with deep blue color |
| 02/12/2009 | WO2009020101A1 Method for producing plant with modified flower morphology |
| 02/12/2009 | WO2007014743A8 Cd33-specific single-chain immunotoxin and method of use |
| 02/12/2009 | US20090042797 Gamma-heregulin |
| 02/12/2009 | US20090042794 Group b streptococcus antigens and corresponding dna fragments |
| 02/12/2009 | US20090042787 Proteolytically cleavable fusion proteins with high molar specific activity |
| 02/12/2009 | US20090042769 Modifications of peptide compositions to increase stability and delivery efficiency |
| 02/12/2009 | US20090042270 Activatable recombinant neurotoxins |
| 02/12/2009 | US20090042216 Method for purifying proteins and/or biomolecule or protein complexes |
| 02/11/2009 | EP2022800A2 Compositions for the therapy and diagnosis of ovarian cancer |
| 02/11/2009 | EP2021467A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same |
| 02/11/2009 | EP1140164B1 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |